Nova Satra Dx is a molecular diagnostics company committed to empowering patients and physicians through the research, development and commercialisation of blood-based tests that provide rapid and accurate detection of cancer based on Asian-specific epigenetic biomarkers.
The company is developing a pipeline of tests based on validated technology, the NovoTect™ technology, to address unmet medical needs in cancer diagnosis specifically for Asian patient populations. Nova Satra’s development pipeline includes molecular diagnostics tests for breast, colon, lung, prostate and stomach cancers.